Canadian Pharmaceuticals & Biotech High Insider Buying

Auxly Cannabis Group

Market Cap: CA$250.9m

Operates as a consumer-packaged goods company in the cannabis products market in Canada.

Organigram Global

Market Cap: CA$204.1m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

HLS Therapeutics

Market Cap: CA$131.4m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

ME Therapeutics Holdings

Market Cap: CA$59.8m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Telescope Innovations

Market Cap: CA$57.4m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

Sernova Biotherapeutics

Market Cap: CA$49.1m

Operates as a clinical-stage biotechnology company in Canada.

Microbix Biosystems

Market Cap: CA$41.3m

A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.

Medicenna Therapeutics

Market Cap: CA$36.5m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Voyageur Pharmaceuticals

Market Cap: CA$31.7m

Engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah.

Rubicon Organics

Market Cap: CA$30.7m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Thiogenesis Therapeutics

Market Cap: CA$29.5m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Pharmala Biotech Holdings

Market Cap: CA$15.2m

A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

Medicure

Market Cap: CA$13.5m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

1CM

Market Cap: CA$12.4m

A multi-jurisdictional cannabis company, retails cannabis, alcohol, tobacco, nicotine, and consumer packaged goods in Canada.

Glow Lifetech

Market Cap: CA$8.7m

An ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products.

Kane Biotech

Market Cap: CA$6.2m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Restart Life Sciences

Market Cap: CA$5.2m

Through its subsidiaries, operates as a biotechnology company in Canada.

Blueberries Medical

Market Cap: CA$5.0m

A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.

Innovotech

Market Cap: CA$4.6m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Grey Matters Health

Market Cap: CA$4.2m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

Delivra Health Brands

Market Cap: CA$3.4m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.

City View Green Holdings

Market Cap: CA$2.3m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.